Los Angeles Capital Management
TXG icon

Los Angeles Capital Management’s 10x Genomics TXG Stock Holding History

Los Angeles Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.8K Hold
725
– – ﹤0.01% 1694
2026
Q1 		$15.4K Sell
725
-33,621
-98% -$672K ﹤0.01% 1819
2025
Q4 		$427K Buy
+34,346
New +$519K ﹤0.01% 956

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Los Angeles Capital Management's TXG Position: Q2 2026 in Review

Los Angeles Capital Management held its 10x Genomics (TXG) position steady in Q2 2026 at 725 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Los Angeles Capital Management first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. The position peaked at $427K in Q4 2025. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Los Angeles Capital Management held 725 shares of 10x Genomics worth $27.8K as of Q2 2026.
  • Los Angeles Capital Management left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1694 holding.
  • Los Angeles Capital Management first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's 10x Genomics position peaked at $427K in Q4 2025.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.